It’s the first FDA approval for a pain medication in 25 years. How does the drug work, and who is it for?

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...

A recovering ketamine addict from Portsmouth warns of the drug's dangers as use soars among young people. The number treated across the region was an increase on the previous year. The early ...

Ben Strahan thought he’d lost the will to live. It had been a long, isolating year for the Reno-based wildland firefighter. The COVID pandemic was still in ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

A new review from the Cochrane Database of Systematic Reviews confirms that antidepressants can effectively reduce symptoms ...

(KGET) – The FDA has approved a new non-opioid painkiller, a potentially significant step ... 50 million Americans who suffer from chronic pain, the newly approved drug could make an impact on the ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration ... placebo-controlled and active-controlled. " ...

A new non-opioid pain medication has been released - and doctors say it is non-addictive. The new drug, branded "Journavx," is the first non-opioid pain pill, and it just got FDA approval.

(The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid ... in two randomized controlled trials of ...

the company that developed the new drug. The FDA's sign-off on the medication comes as the agency says it is prioritizing supporting the development of non-opioid pain treatment. Suzetrigine is ...